337 views | 7 years ago
Is genetic screening better at prediction of disease than the current traditional phenotypic methods? Do we have enough expertise to move genetic diagnosis into the clinic? Is direct-to-consumer genetics...
187 views | 7 years ago
Concern is often expressed about the possibility of reidentification of participants in dementia genetic studies. How big of a problem is that in reality? How does patient consent play into DNA sequences...
255 views | 7 years ago
Should we do ever larger genome-wide association studies? Will large scale population sequencing studies for dementia be productive in going after rare variants? Should we be investing more effort in...
3149 views | 7 years ago
Illumina Field Applications Scientist Jill Castoe and Bioinformatics Support Scientist Ana Sanchez discuss the benefits of instrument performance monitoring through Illumina Proactive, a service in...
1081 views | 7 years ago
Illumina Bioinformatics Support Scientist Ana Sanchez shares IT requirements for implementing Illumina Proactive, an instrument performance monitoring service provided by Illumina that can increase...
2621 views | 7 years ago
Families of children with an undiagnosed disease often face years-long diagnostic odysseys. Hear from health care providers and families who have participated in iHope, a philanthropic program from...
5443 views | 7 years ago
Opening in Q2, 2019 the Madison, WI site is a 133,000 SF purpose-built GMP facility that has been designed and constructed for Illumina’s Enzyme Manufacturing. This location is for internal illumina...
9551 views | 7 years ago
Paula Dowdy, Senior Vice President and General Manager of Illumina Europe, Middle East and Africa talks about the new Illumina Centre in Granta Park, where groups can innovate, collaborate, and learn...